Yasmina Abajas
Chapel Hill, NCNPI 1063654259
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $85,023 of the $116,886 with a category attached, or 72.7%. 9 manufacturers reported payments, led by Sanofi at 36.0% of the total. 2025 is the largest year on record at $31,523, 6.9 times the $4,570 reported in 2019.
Across 103 payments — averaging $1134.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$42K
- Genentech USA, Inc.$32K
- Pfizer$14K
- HEMA Biologics, LLC$12K
- Sanofi US Services Inc.$11K
- Bioverativ Therapeutics Inc.$3K
- plus $3K from 3 others
Across 176 payments — averaging $305.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Daiichi Sankyo Inc.$53K
- Grifols Therapeutics LLC$750
What the payments were for
- Consulting fees$85,02373%
- Speaking & faculty fees$17,85515%
- Travel & lodging$10,7439%
- Food & beverage$3,2523%
- Education$130%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 30 | $42,101 |
| Genentech USA, Inc. | 30 | $32,055 |
| Pfizer | 15 | $14,161 |
| HEMA Biologics, LLC | 23 | $11,926 |
| Sanofi US Services Inc. | 1 | $10,535 |
| Bioverativ Therapeutics Inc. | 1 | $2,813 |
| CSL Behring | 1 | $2,055 |
| Bayer | 1 | $1,076 |
| Octapharma USA, Inc. | 1 | $165 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.